CliffBio
small molecule

ISOPTO CETAPRED

PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameISOPTO CETAPRED
Active ingredientPREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Strength0.25%;10%
Dosage formSUSPENSION
RouteOPHTHALMIC
ModalitySmall molecule
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISOPTO CETAPRED patent cliff — loss of exclusivity — | CliffBio